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Abstract
Background Important regional disparities in patterns of care in breast cancer have recently been described. In Switzerland,
nationwide data on hospitalisations have been collected since 1998. They have not been used up to now to explore space–time
patterns and trends of breast cancer healthcare-related procedures for control and health planning purposes. We aimed to assess
geographical and temporal variation of mastectomy rates.
Methods Bayesian negative-binomial spatio-temporal models have been applied. Covariates included patient characteristics as
provided in the hospital data, data on mammography screening programme duration, and surgeon and gynaecologist density.
Results We analyzed more than 70,000 patients. Mastectomy rates declined from 43% to 30% in Switzerland between 2000 and
2012 for patients aged 50–69 and from 61% to 43% for those 70+, and remained stable for those under 50. Important geograph-
ical differences in rates were present. Rates were significantly influenced by age [relative rate ratio (RR) 50–69: 0.92, RR 70+:
1.25], differences in co-morbidity (RR one co-morbidity: 1.17, RRmore than one: 1.35), higher surgeon or gynaecologist density
(RR surgeons: 1.01, RR gynaecologists: 1.06). Regions in the French-speaking part (RR: 0.72) and/or with mammography
screening programmes showed significantly lower rates (RR: 0.87). No difference was found for patients in different socio-
economic groups or with different insurance types.
Conclusion This research unveiled important differences in mastectomy rates in Switzerland. The results play an essential
role in the identification of regions where special attention is required, and indications for extensive surgery in breast
cancer should be revisited.
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Introduction
Female breast cancer is the most frequently diagnosed cancer
in the female Swiss population. In the period of 2010–2014,
almost 6000 new cases of breast cancer were diagnosed per
year, corresponding roughly to 30% of the female cancer in-
cidence. Within Switzerland, age-standardised incidence rates
for breast cancer vary between 83.1/100,000 PY in Appenzell
Innerrhoden and 136.8/100,000 in Jura (NICER 2017).
Differences in uptake of screening activities (mammography
screening in women) contribute as much to differences in
incidence as do other known risk factors such as age and
genetic predisposition, overweight and obesity, reproductive
factors, and presumably hormone replacement therapy
(Kumle 2008; McPherson et al. 2000).
Breast surgery is the cornerstone in the treatment of local-
ized breast cancer, representing 95% of all newly diagnosed
BC patients. Adjuvant therapies (radiotherapy, endocrine ther-
apy, and chemotherapy) are aimed to reduce the risk of relapse
and overall survival. While adjuvant therapies are generally
performed in the ambulatory setting, breast surgery is per-
formed in Switzerland in an in-patient setting. Data on this
hospital procedure is the basis for this study. Mastectomy
has been the traditional type of breast surgery until results
from well-designed randomized trials in the 1980s showed,
that less mutilating surgical procedures had similar rates of
overall survival and disease-free survival to those for mastec-
tomy. Preserving the most part of the breast (breast-conserving
surgery) through procedures such as lumpectomy or
quadrantectomy was aimed at optimal disease control while
preserving the quality of life (Veronesi et al. 1981). The study-
update with a 20-year follow-up confirmed the preliminary
findings, establishing the concept of breast conservation as a
standard of care (Veronesi et al. 2002). In fact, mastectomy
patients compared to breast-conserving surgery patients usu-
ally reported less positive body image and sexual functioning
(Montazeri 2008). There are, however, several reasons to per-
form a mastectomy in contrast to a breast-conserving surgery
(BCS). Reasons might be of a personal, medical, or preventive
nature, such as an increased risk of getting a second cancer
due to BRCA mutations. Medical reasons include larger tu-
mours, multiple areas of the breast affected by cancer, and
inflammatory breast cancer. BCS should in most cases be
combined with radiotherapy to result in the same survival as
mastectomies (McLaughlin 2013). Mastectomies might there-
fore also be chosen when radiation therapy is medically con-
traindicated, after previous BCS with radiation therapy, or on
a personal level, if the patient prefers to avoid radiotherapy,
e.g., living far from facilities offering radiation therapy (Mac
Bride et al. 2013). In comparison with BCS, mastectomy is a
more serious procedure that sometimes results in complica-
tions such as infection, poor healing, and lymphedema, and
requires longer hospital stays (Andersen and Kehlet 2011).
Discomfort and pain are less after BCS, but (time-
consuming) radiation and surveillance by mammography are
necessary and might result in higher anxiety about recurrence.
In Switzerland, geo-referenced data on hospitalisations in-
cluding socioeconomic characteristics of the patient, diagno-
sis, and procedures have been collected yearly by the Federal
Statistical Office (FSO) since 1998 and cover the whole coun-
try. To our knowledge, the wealth of information provided in
this database has not been fully explored to assess space–time
patterns and trends of breast cancer healthcare-related proce-
dures for control and health planning purposes.
There has beenmuch debate on the role of medical care in the
discussion of social inequalities in health. Access inequalities to
early detection, appropriate care, and state of the artmanagement,
as well as differences in tumour biology, are possible explana-
tions for survival differences between socio-economic classes.
Regional disparities have been described for Switzerland affect-
ing income, access to services including access to healthcare
services, education, and other socioeconomic factors.
Availability of public or private resources to be allocated to
health is high. Switzerland is one of the richest countries in the
world and has among the highest expenditure per person on
health and direct purchasing power adjusted costs for cancer.
In Switzerland the standard of care is high, uptake of new
drugs is above average within Europe (Jonsson and Wilking
2005), and life expectancy is one of the highest in the world.
However, since healthcare policies are mainly developed at
the cantonal level, there is a considerable amount of geograph-
ical variation in health expenditures, control programmes, and
treatment procedures. Opportunistic screening is common, es-
pecially in the urban areas of cantons with cancer registries,
but little is known about regions not covered by cancer regis-
tries (Wanner et al. 2001).
Important regional disparities in the state-of-the-art man-
agement of breast cancer among regions covered by cancer
registration have recently been published (Ess et al. 2010).
Disparities included surgical as well as non-surgical manage-
ment issues. Predictors of guideline compliance on the patient
level were treatment by a surgeon with high caseload, resi-
dence, and age of the patient, but not socio-economic factors.
They described pronounced differences in mastectomy rates
from 24% in Geneva to 38% in St. Gallen in 2003–2005. The
differences persisted after adjustment for age and tumour size.
Using the hospital discharge dataset, we can assess if these
differences persisted over time and how their results relate to
the situation in the whole country.
The aim of this research is to assess spatio-temporal pat-
terns of mastectomy rates in Switzerland and explore their
relationship to socioeconomic disparities and screening pat-
terns. The assessment of the geographical variations in the
country will help to identify regions in which special attention
is required to reduce healthcare inequalities and their impact
on the health of the community.
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Methods
Data from the Swiss Hospital Discharge database until 2012
was retrieved from the Federal Statistical Office (FSO). The
database was initiated in 1998 and includes each inpatient
hospitalisation discharge with information on the age, the gen-
der of the patient, year of hospitalisation, diagnosis and co-
morbidities, treatment procedures, class of stay, and adminis-
trative characteristics. Its data is available for research in
anonymised form in two variants, where we used the geo-
graphic variant with information on the region of patients’
residence and canton of hospitalisation, over the type of hos-
pital. In both cases, the exact hospital cannot be identified. We
excluded data before 2000 due to insufficient data quality,.
I.e., unique person identifiers were missing in a significant
proportion. The FSO described data completeness and quality
issues in the first years after the start of the data collection.
Although participation is mandatory, only 85% of hospitals
representing 73% of cases sent data for 1999 (Bundesamt für
Statistik 2003). Since 2000, data have continuously improved,
reaching 99% of hospitals representing 91% of cases in 2002,
and reached 100% in 2011 (BFS 2017). In our study, we
included females with breast cancer (BC, ICD-10 codes
C50.0-C50.9) as the main reason for hospitalisation, who
had at least one BC-related surgery as defined below in any
hospital stay, in order to exclude patients solely treated with
palliative intentions or BC-unrelated conditions. Patients who
presented with distant metastases at first visit (ICD-10 codes
C78-C79) were also excluded. Patients were only counted
once per year even with multiple admissions, but counted
again when they underwent surgical treatment for breast can-
cer in another year.
The outcome of interest was the (crude) ratio of pa-
tients with mastectomies per all included patients and its
trend per hospital region (canton). Data on treatments
were coded according to the Swiss operation classification
(CHOP) of 2012. CHOP codes begin with the letter ‘Z’
followed by two to six numbers in groups of two, sepa-
rated by a period. Operations involving the breast have
codes beginning with BZ85^. To identify women with
mastectomies we used the codes BZ85.23^ and BZ85.33^
to BZ85.48^. As (therapeutic) surgeries we used addition-
ally the codes BZ85.2^, BZ85.20^– BZ85.22^, and
BZ85.25^. Other codes in the BZ85^-group include diag-
nostic procedures, reconstructions, transplantations, etc.
We assessed the comorbidity score for each patient
based on the hospital record. We used the Charlson score
with ICD-10 modification, and performed the calculation
using the Stata program "charlson". For the score, we
excluded the breast cancer and any breast cancer-related
axillary lymph node metastases, in order to reflect the
impact of additional health disorders and not to mask
any further cancer disease.
From the hospital databases, we determined breast cancer
patient characteristics for each region and year. After prior
analysis, patients were categorised into three age groups:
< 50 years old, 50–69 years old, and more than 70 years old.
This coincides with the age of invitation (50–69-year-olds) in
Swiss mammography screening programmes. We categorized
patients also by number of admissions (one versus multiple
BC-related admissions), by number of BC surgeries (one ver-
sus multiple BC surgeries), the comorbidity score (score of
0 = only BC vs score of 1 vs scores of 2 or more) and insur-
ance class (basic vs half-private or private insurance). This
insurance class is a proxy for affluence but may in part also
reflect differences in treatment. While in principle the same
medical services are provided in all classes, patients within the
private class are normally treated by more senior staff.
We evaluated also a different covariate in relation to socio-
economic status. Data on socio-economic position (SEP) by
municipality was provided by the Swiss National Cohort
(SNC 2015) based on census data of 2000, includingmeasures
of affluence, education, etc. We linked the municipality of
residence of the patient to the SEP score of the municipality,
and grouped all BC patients by SEP quartile. The score ranged
from 55 to 71, with the median being 64 and the interquartile
range being 60–67.
We furthermore included covariates in relation to the anal-
ysis region, the canton. Data on language region were re-
trieved from the FSO (Swiss Federal Statistical Office
2017). Regions were classified according to their predominant
language into German, French, or Italian/Romansh. Patterns
of mammography screening were obtained as years of
population-based mammography screening programmes by
year and canton (swiss cancer screening 2015). The regions
were classified according to the existence of a population-
based mammography screening programme for a given year.
The number of surgeons and gynaecologists per 1000 popu-
lation by year and canton was retrieved from the Swiss
Medical Association (FMH 2017). The FMH provides num-
bers only by main medical discipline. Statistics on hospital
type and volume were retrieved from the Federal Office of
Public Health (FOPH) (BAG 2014). Since some influencing
factors described by other countries, such as urbanisation or
hospital type profiles, were not available in this study, it can
not be ruled out that any of the above mentioned variables
could act as a proxy for some unobservable factor. Although
this might be the case for any analytical study, we additionally
evaluated the overall hospital type and caseload distribution
by canton and its relation to differences in mastectomy rates.
In the analysis, the cantons of Uri, Obwalden, and
Nidwalden, and of Appenzell Innerrhoden and Appenzell
Ausserrhoden were combined in two regions in order to in-
crease power.
We assessed space–time patterns of mastectomy rates by
fitting Bayesian areal models with temporal trends. Bayesian
J Public Health (Berl.): From Theory to Practice (2020) 28:71–80 73
methods have been applied extensively in recent years for
modelling spatial data because they allow flexible modelling
and inference, and provide computational advantages via the
implementation of Markov chain Monte Carlo (MCMC)
methods. The models produce smooth maps of the observed
rates, highlighting patterns of the disease. They are also useful
in establishing associations between disease rates and poten-
tial area-related risk factors, taking into account geographical
correlation. By adding a time dimension, Bayesian spatio-
temporal models indicate changes of geographical patterns
over time, and determine how the disease evolves over time
in different regions and different groups of the population. In
our model, the choice of AR(1) for the time trend was based
on a prior analysis.
To our knowledge, this is the first study which will utilise
the Swiss Hospital database to explore space–time patterns of
care in oncology research.
Patient characteristics, socio-economic status, screening
patterns, linguistic region, and surgeon and gynaecologist
density were explored by including these factors as covariates
in the model. The geographical unit of analysis was the canton
of the hospital.
For each patient characteristics combination (insurance
type, SEP quantile, comorbidity, admissions, surgeries) ob-
served counts of mastectomies Yijt in canton i (i = 1,…,N),
age group j and year t to follow a negative binomial distribu-
tion Yijt~NegBin(μijt). Random effects, as well as possible
trends, weremodelled on the log of the meanmastectomy rate.
Time dimension was included as an autoregressive term
[AR(1)] conditioned on the mastectomy rates in the year 2000.
log μijt
 
¼ log Pijt
 þ αþ ∑XTitsβs þ γ j
þ δ þ ε j
 
log μij t−1ð Þ
 
þ Φi
where Pijt is the number of patients, Xits the vector of covari-
ates s related to canton i and year t, βs the coefficients of
associated covariates, γj effects of age group j, δ time trend
and εj interaction of time and age group j. Spatial correlation
by random effects Φi on canton level i, modelled via a condi-
tional autoregressive (CAR) process. Spatial dependency
among the cantons was introduced by the conditional prior
distribution of Φi with
Φi∼N
γ∑Nq ¼ 1
q≠i
ciqΦq
wi
;
σ2
wi
0
BBB@
1
CCCA
where ciq indicates the degree of spatial influence of canton i
to the remaining cantons, taking the value 1 if they are adja-
cent and 0 otherwise, and γ quantifying the overall spatial
dependence and wi being the number of neighbours of canton
i. The final model was selected by stepwise selection based on
lowest DIC (deviance information criterion) score, including
comparison of Poisson vs negative binomial distribution and
universal vs single spatial random effects.
From the model estimates we produced maps with the rel-
ative differences of the estimated (crude) rates for all ages and
by age group combined by 4-year periods compared to the
national mean for 2001–2012.
Results
A total of 71,655 patients were included in our study. Table 1
summarizes the characteristics of included patients: 22% were
aged < 50 at hospitalisation, about half 50–69 and 29% 70 or
Table 1 Characteristics of patients included in the study
Patients %
Age
0–39 3601 5%
40–49 12,325 17%
50–59 16,447 23%
60–69 18,603 26%
70–79 13,332 19%
80+ 7347 10%
Language region (place of treatment)
German 47,200 66%
French 19,291 27%
Italian 5164 7%
Mammography screening duration in 2012 (place of residence)
0 (no programme) 54,111 76%
1–4 years 5,369 7%
5–9 years 6,887 10%
10+ years 5,288 7%
Insurance class
1 basic 43,505 61%
2 half-private 18,159 25%
3 private 9,991 14%
Comorbidity score (excl. breast cancer)
0 (only BC) 64,857 91%
1 4923 7%
2+ 1875 3%
No. of admissions
1 45,546 64%
2–4 24,334 34%
5+ 1775 2%
No. of surgeries
1 55,400 77%
2 13,717 19%
3+ 2538 4%
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over. Two-thirds were treated in the German-speaking region,
27% in the French-speaking region, and 7% in the Italian-
speaking region. Sixty-one percent of patients had mandatory
basic insurance, 25% half-private, and 14% private insurance.
Nine percent of patients had further co-morbidities at
hospitalisation, 64% were only hospitalised once, and 77%
had only one breast cancer-related surgery. Three-quarters of
patients lived in a canton with no established mammography
screening programme at their time of hospitalisation (Table 1).
Overall crude mastectomy rates decreased from 48% of all
surgically treated women in 2000 to 36% in 2012 (Fig. 1). The
rate and trend for mastectomy rates are quite different for the
three age groups studied. While rates for women below
50 years of age are more or less stable around 40%, with an
apparent slight increase, rates in both other groups decreased.
The strongest decrease can be observed in the 70 or over age
group, from 61% in 2000 to 43% in 2012.Mastectomy rates in
50–69-year-olds were much lower and decreased at a slower
pace, from 43% in 2000 to 30% in 2012.
For the Bayesian regression, the DIC was lowest when all
available covariates were included in the model.
The rates vary considerably among the cantons. Figure 2
visualises the relative differences in estimated mastectomy
rates for all ages combined by 4-year periods compared to
the national mean for 2001–2012. Maps with relative differ-
ences by age group and periods are presented in section
Annex 2 (Figs. 3, 4, and 5). These show that while the overall
mastectomy rates stayed high throughout in central
Switzerland (UR/OW/NW), rates decrease considerably from
high to average in the age group < 50 years. Geographical
differences in 50–69-year-olds and those 70 or over are with
the exception of Zürich nearly identical. In 50–69-year-olds
nearly all cantons fall in the same relative rate category as the
respective canton in the 70 or over group in all time periods,
with the exception of the canton Zurich, where a stronger
reduction was observed for the 70 or over group. The spatial
patterns and trends in the less than 50-year-olds are different
from the other two age-groups (see Annex 2, Figs. 3, 4, and 5).
The regression results are presented as rate ratios (RR) and
95% Bayesian credible intervals (CI) in Table 2. When taking
spatial dependence of the analysis regions as well as other
confounding factors into account, the time trends included in
the model did not show significance.
Statistically important positive effects, increasing the rate
of mastectomies, were age 70 or over (RR 1.25, CI:1.21–
1.29), co-morbidities (score of 1: RR 1.17, CI: 1.11–1.25;
score of 2+: RR 1.35, CI: 1.27–1.45), surgeon and
gynaecologist density (surgeon density: RR 1.01, CI: 1.00–
1.02, gynaecologist density: RR 1.06, CI: 1.05–1.06).
Significant decreasing effects were the presence of organised
mammography screening programmes (RR 0.87, CI: 0.82–
0.95), treatment in the French language region (RR 0.72, CI:
0.62–0.82) and age 50–69 (RR 0.92, CI: 0.87–0.95). Not sig-
nificant, but important for model fit in terms of DIC, were the
number of surgeries per patient and SEP quartile and insur-
ance type of patients.
Discussion
Our study shows considerable geographical differences in the
proportion of women that have a mastectomy as the definitive
surgical procedure for breast cancer. This difference persists
after taking into account differences in age and case mix (co-
morbidities). In most regions, the rate of mastectomies de-
clined over time or was already low.
Fig. 1 Observed mastectomy
rates by time and age group in
Switzerland
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We were also able to show the importance of taking spatial
dependency and other influencing factors into account, rather
than limiting the analysis to age groups. We were able to show
that the observed differential trends in the age groups were
likely a combined result of trends in all factors.
Nevertheless, a significantly higher proportion of 70+ year-
olds received mastectomies compared to < 50-year-olds, who
again had a significantly higher rate of mastectomies than the
50–69-year-olds.
Influence of covariates
Patients with a higher number of comorbidities had a signifi-
cantly higher mastectomy rate. This is in line with previous
reports. Patients with a higher number of co-morbidities and
more severe health conditions tend to receive mastectomies in
order to avoid further deteriorating effects of otherwise neces-
sary therapies such as neo-adjuvant chemotherapy and adju-
vant radiation (Bernardi et al. 2008).
We adjusted for multiple admissions and multiple breast
surgeries per patient. Both factors are strongly overlapping.
More admissions/surgeries per patient would suggest that
these patients underwent re-excisions and/or mastectomies
after a BCS with an insufficient result. More than three-
quarters of patients in our study received only one surgery,
and the variation in this rate was small. However, the inclu-
sion of and adjustment for both characteristics lead to a
significantly better model fit. Due to the data structure, we
deemed this approach superior to excluding patients with
mastectomies after BCS.
We could show that patients were treated similarly in
terms of mastectomies regardless of socio-economic
group or insurance type. These variables remained in the
final model since they increased model fit. In New
Zealand also, no differences in mastectomy rates among
different socio-economic groups were found when adjust-
ed for several factors. They had no data on insurance type,
but described higher mastectomy rates in public versus
private hospitals (Seneviratne et al. 2017).
Mastectomy rates in the French language region were
significantly lower. This is the language region where mam-
mography screening programmes started the earliest.
However, we included the existence of population-based
mammography screening programmes in our model, and
showed an additional significantly reduced rate of mastec-
tomies of about 13%. In 2001, three cantons had established
screening programmes. Up to 2012, ten cantons had had
screening programmes for more than 10 years, and three
for at least 5 years. Screening programmes lead to a down-
shift in stage distribution in the respective cantons (Bulliard
et al. 2011). And Ess et al. showed a significantly lower rate
of mastectomies in Switzerland for breast cancer patients
with lower stages (Ess et al. 2010).
While the results in terms of co-morbidities and screening
were expected, the other significant covariates indicate possi-
ble starting points for reducing geographical disparities. It
should be kept in mind that possibly further confounding var-
iables exist, which were or could not be included in the model.
More mastectomies were performed in cantons with
more surgeons or gynaecologists per 1000 population.
This could have several reasons. On the one hand, those
variables may have acted as a proxy for hidden variables
not available to this study such as urbanisation or hospital
type profiles. Or they may have captured some of the time
trends in mastectomy rates, since the rate of surgeons and
gynaecologists was also declining at the same time. One
Fig. 2 Estimates of mastectomy
rate ratios in Switzerland by time
period in relation to the overall
mean
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reason could be that women choose mastectomies more
easily if immediate breast reconstruction is available
(McLaughlin 2013), i.e., with a higher concentration of
plastic surgeons. Also, lower case-volumes have been pre-
viously linked to higher mastectomy rates (Hawley et al.
2006). However, it is not possible to conclude a lower
case-load from an elevated surgeon or gynaecologist den-
sity. In addition, expansion of medical services may lead
to performing unnecessary procedures. But whether any
of this played a role in the results in relation to the sur-
geon or gynaecologist density could not be answered by
this study, since this type of data was not available.
After adjustment especially for co-morbidities, it is surpris-
ing that those over 70 have more mastectomies than 50–69-
year-olds. The significantly higher rates in the elderly patients
are not observed in a similar magnitude in other countries.
Cultural and personal factors may have played a greater role
in this age group, but the magnitude is a reason for concern
and would need more detailed research.
No overall decline in mastectomy rates was observed
in the age group of < 50-year-olds. This might be due to
lower rates a priori and/or a higher proportion of heredi-
tary forms of breast cancer where radical mastectomies of
both breasts are combined curative and preventive mea-
sures (Rebbeck et al. 2004). However, mastectomy is not
universally used for treating hereditary forms of breast
cancer and the rate might change over time with reviewed
evidence (Paradiso and Formenti 2011).
Table 2 Mastectomy rate ratios,
multivariate Bayesian regression
results including 95% credible
interval (CI)
Median 95% CI
Time (1-year change) 1.008 1.003 1.013
Time:age group interaction
time: < 50 years 1 (reference)
time: 50–69 years 0.995 0.987 1.001
time: 70+ years 0.999 0.993 1.005
Age group
< 50 years 1 (reference)
50–69 years 0.915* 0.870 0.953
70+ years 1.254* 1.205 1.290
Co-morbidity score
0 (only BC) 1 (reference)
1 1.171* 1.105 1.250
2+ 1.349* 1.268 1.454
Insurance class
Basic 1 (reference)
Half-private/private 0.982 0.951 1.015
Multiple admissions 1.431* 1.033 1.790
Multiple BC surgeries 1.231 0.959 1.674
Average SEP at patients’ residence
Q1 (lowest quartile) 1 (reference)
Q2 0.965 0.926 1.011
Q3 0.970 0.930 1.019
Q4 (highest quartile) 0.987 0.950 1.041
Language region of treatment
German 1 (reference)
French 0.719* 0.615 0.815
Italian/Romansh 0.878 0.792 1.013
Hospital region profiles
Surgeon density per 1000 population 1.010* 1.002 1.015
Gynaecologist density per 1000 population 1.058* 1.045 1.063
Mammography screening programme exists 0.868* 0.820 0.949
Spatial variation 0.3098* 0.3882 0.5353
* denotes significant difference from 1 for covariates. Spatial variation (standard deviation of spatial random
effects): a value of 0 means that there is no spatial correlation
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Comparison of results with previous publications
Regional differences in mastectomy rates in 2003–2005
have been previously reported for Switzerland (Ess et al.
2010). Ess et al. analysed data from 11 cantons covering
about half of the Swiss population, with the main focus on
patterns of breast cancer care. They described significant-
ly different rates of mastectomies among some study re-
gions. When compared with our results, the participating
regions in the above study all had lower mastectomy rates
in the spectrum of all cantons, with the exception of
Appenzell Innerrhoden and Ausserrhoden.
Trends and influencing factors of mastectomy rates
have been studied for various countries. The rates and
observed trends vary greatly among the countries. Most
studies found a significant decrease in mastectomy rates,
with the exception of rates in Alberta, Canada, and France
(Fisher et al. 2015; Rococo et al. 2016). Most studies also
found significant geographical variation within the coun-
try. In the USA (excluding patients above 80 years of
age), the trends among the age groups are comparable to
our findings, as well as the range of relative differences
among the regions ranging from 0.71-times the total av-
erage in Connecticut and 1.32-times the average in
Louisiana (Habermann et al. 2010). The regional variation
in the Netherlands was significant and had a similar mag-
nitude to our findings, with adjusted odds ratios ranging
for < 40-year-olds from 0.7 to 1.49, for 40–69-year-olds
from 0.65 to 1.45, and for those 70 or over from 0.65 to
1.85 (van Steenbergen et al. 2010).
Strengths and limitations
One major limitation of the study is that the hospital data did
not include information on the breast cancer stage and no
intent of treatment (palliative or curative).Moreover, we could
not distinguish the breast cancer by laterality, since this infor-
mation was only included recently in the dataset and therefore
missing for most of the years. In order to reduce a possible
bias because of preventive contralateral mastectomy, we only
counted one mastectomy per woman.
A second major limitation is that no detailed informa-
t ion about s ing le hospi ta l s was ava i lab le . For
anonymization purposes, the Federal Statistical Office
(FSO) pooled all hospitals in a canton in the available
dataset, making it impossible to distinguish them from
another. Therefore, we had no information about the type
of hospital (university, central, rural, private etc.) in which
a patient was treated. However, the Swiss cantons are
relatively small, and from the general hospital statistic
provided by the FSO, we were able to evaluate the overall
hospital type and caseload distribution by canton (see
Annex, Fig. 6) as a rough proxy of hospital type and
caseload for breast cancer patients. Regardless of the
grouping of hospital types, no direct correlation with mas-
tectomy rates could be observed at this level of detail. In
other countries, both type and hospital volume were de-
scribed as significant factors for mastectomy rates, e.g., in
Finland (Peltoniemi et al. 2011). While this factor might
be a key target to approach reducing disparities, our study
specifically chose to analyse geographical patterns, since
health policy is mainly developed on cantonal level. In
particular, our study gives important insight into which
areas might benefit most from interventions, i.e., in re-
source allocation and policy planning.
The surgeon density was only available for the profession
as a whole and not by area of expertise or case-load.
Therefore, the results and possible implications need further
research. Urbanisation could not be used since the hospital
data was only available on a cantonal level.
The advantage of the current study is the population-based
nature of the database, resulting in a large representative sam-
ple of over 70,000 patients included in our study. The results
mirror the real-world situation in Switzerland. Bayesian re-
gression models have not been employed until now to explore
differences in cancer management.
Conclusion
This is the first time full benefit was taken from the informa-
tion of the national hospital discharge database to analyse
geographical differences in breast cancer care, in particular
mastectomies. Mastectomy rates declined importantly in
Switzerland in 2000–2012 for patients aged 50–69 and 70+,
and remained stable for those under 50. Rates were highest for
those 70 and above and lowest for those aged 50–69. Regional
differences in mastectomy rates are as pronounced in
Switzerland as in other countries.
We showed the importance of taking spatial dependence
and other influencing factors into account when comparing
mastectomy rates among age groups and geographical areas.
Patients from different socio-economic groups or with
different insurance types did not receive different treat-
ment with regard to mastectomies. Rates were significant-
ly influenced by differences in co-morbidity. Regions with
a higher surgeon and gynaecologist density had higher
rates of mastectomies, and regions with mammography
screening programmes lower rates. In general, it is impor-
tant to note that higher or lower than average rates are not
the same as Btoo high^ or Btoo low^ since this study is of
ecological design. The decision to undergo mastectomy or
BCS is ideally done on an individual level by a well-
informed patient, and is based on medical reasons and
personal preferences. Both types of surgery have their
advantages and disadvantages, but analysing the
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differences in rates and trends may help in gaining a
clearer insight into the decision-making process in the
surgical treatment of breast cancer. This research unveiled
important information which until now was not available
for the whole country. Further research is needed to un-
derstand the combined role of region-specific and
hospital-specific factors, such as hospital type and vol-
ume, on breast cancer care differences.
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